Helios Technologies, Inc.
HLIOHelios Technologies, Inc. (HLIO) is a global manufacturer specializing in motion control and electronic control solutions for various industrial markets, including aerospace, defense, and industrial automation. The company focuses on high-performance hydraulic, electronic, and mechanical components designed to improve efficiency and reliability in demanding applications. Helios is known for its innovative technologies and extensive product portfolio, serving clients worldwide across multiple sectors.
Dividend History
Investors can expect a dividend payout of $0.12 per share, scheduled to be distributed in 6 days on July 24, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 24, 2026 | $0.12 | 2026-07-10 | 2026-07-10 |
| April 27, 2026 | $0.12 | 2026-04-13 | 2026-04-13 |
| January 21, 2026 | $0.09 | 2026-01-07 | 2026-01-07 |
| October 21, 2025 | $0.09 | 2025-10-07 | 2025-10-07 |
| July 21, 2025 | $0.09 | 2025-07-07 | 2025-07-07 |
Dividends Summary
- Consistent Payer: Helios Technologies, Inc. has rewarded shareholders with 103 dividend payments over the past 22 years.
- Total Returned Value: Investors who held HLIO shares during this period received a total of $11.31 per share in dividend income.
- Latest Payout: The most recent dividend of $0.12/share was paid 82 days ago, on April 27, 2026.
- Yield & Schedule: HLIO currently pays dividends quarterly with an annual yield of 0.52%.
- Dividend Growth: Since 2004, the dividend payout has grown by 200.0%, from $0.04 to $0.12.
- Dividend Reliability: HLIO has maintained or increased its dividend for 39 consecutive payments.
Company News
Helios Technologies reported Q2 2025 earnings with revenue of $212.5 million, beating estimates but showing a 3% year-over-year decline. The company experienced mixed regional performance across its Hydraulics and Electronics segments, with challenges in margins and ongoing global trade uncertainties.
Bragar Eagel & Squire, P.C. is investigating potential securities law violations and other unlawful business practices by Metagenomi, Target Hospitality, Helios, and LegalZoom.
Helios (HLIO) shares fell 14.6% after KeyBanc analyst Jeffrey Hammond downgraded the stock's rating from Overweight to Sector Weight, citing uncertainty around the company's future leadership.
KeyBanc downgraded Helios Technologies' stock from Overweight to Sector Weight due to uncertainty surrounding the company's leadership transition and softening market conditions in the Agriculture and Construction sectors.
Mainz Biomed shares jumped 16% in pre-market trading after the company announced submission for the FDA Breakthrough Device Designation for its next generation CRC screening test. Several other stocks also saw significant pre-market movement.
